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PRIVACY OF INFORMATION AND 
DNA TESTING KITS 
Shanna Mason 
The 2017 holiday season showed that more people than ever “gave the gift of 
spit.”1 This popular gift—a direct to consumer DNA testing kit—requires a 
person to discharge their saliva, or provide a cheek swab to reveal information 
about a person’s ancestry, or predispositions to certain diseases.2 In 2017, 
AncestryDNA sold roughly 1.5 million kits from Black Friday through Cyber 
Monday, triple the amount of sales from 2016.3 “As more people learn about the 
role genetics play in healthcare and the cost of obtaining these at home DNA 
tests continue to decrease, the worldwide market of direct-to-consumer genetic 
tests could triple over the next five years.”4 These kits are designed to give 
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School of Law; Bachelor of the Arts 2016, The Pennsylvania State University. The Author 
would like to thank Katrina Velasquez, her mentor on this comment and the associates and 
editors of the Catholic University Journal of Law and Technology for their hard work and 
skillful editing. 
 
 1 Megan Molteni, Ancestry’s Genetic Testing Kits Are Heading For Your Stocking This 
Year, WIRED (Dec. 1, 2017, 7:00 AM), https://www.wired.com/story/ancestrys-genetic-
testing-kits-are-heading-for-your-stocking-this-year. 
 2 See U.S. NAT’L LIBRARY OF MED., What is direct-to-consumer genetic testing, 
GENETICS HOME REFERENCE (Mar. 13, 2018), 
https://ghr.nlm.nih.gov/primer/testing/directtoconsumer (describing direct-to-consumer 
genetic testing as bypassing the need for prior approval from doctors or insurance 
companies, because the kits are sold directly to consumers via television, print 
advertisements, and the internet). 
 3 Melissa Anders, DNA Ancestry Test Kits Are Hot Holiday Gifts Despite Privacy 
Concerns From Some, FORBES (Dec. 6, 2017, 10:00 AM), 
https://www.forbes.com/sites/melissaanders/2017/12/06/dna-ancestry-test-kits-are-hot-
holiday-gifts-despite-privacy-concerns-from-some. 
 4 Mike Miliard, Direct to consumer genetic testing set for big growth despite clinical 
and ethical challenges, HEALTHCARE IT NEWS (Jan. 15, 2018, 3:16 PM), 
http://www.healthcareitnews.com/news/direct-consumer-genetic-testing-set-big-growth-
despite-clinical-and-ethical-challenges; see also Kira Peikoff, Fearing Punishment for Bad 
Genes, N.Y. TIMES, Apr. 8, 2014, at D1 (describing the cost of at home genetic testing 
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consumers access to information that was previously only available through a 
doctor.5 Now, consumers are looking for more control over their own health and 
healthcare, such as developing personalized treatment or ensuring precise 
medicine management.6 This can be achieved with the information derived from 
affordable genetic testing.7 
Affordable genetic testing raises issues that not many consumers have 
considered. That is, what type of privacy information is being given up when 
submitting to these tests? While there are some federal regulations that aim to 
protect individual’s privacy rights with respect to their genetic information, 
more needs to be done. 
First, this comment will discuss the popularity of direct-to-consumer DNA 
Testing Kits (“Testing Kit”) and certain privacy risks that are likely unknown to 
the individual consumer. Next, this comment will discuss current federal 
regulations that are designed to protect individuals from being treated adversely 
based on their genetic markers. Then, this comment will address the 
shortcomings of the Health Insurance Portability and Accountability Act of 1996 
(HIPAA), as well as the Genetic Information Nondiscrimination Act of 2008 
(GINA). Finally, this comment will conclude that GINA needs to be expanded 
to address legal matters outside of just the employment and health insurance 
spheres. 
I.  BACKGROUND INFORMATION 
A.  DNA Testing Kits 
In an age where a person can swab their cheek at home and gain access to 
valuable information regarding their genealogy, ethnic roots and family ties, the 
popularity of direct-to-consumer DNA Testing Kits has skyrocketed.8 In 
addition, people can discover if their genetic makeup reveals a predisposition 
                                                          
decreasing substantially from ten years earlier). 
 5 See U.S. NAT’L LIBRARY OF MED., supra note 2. 
 6 Miliard, supra note 4; Consuelo Wilkins, Putting The Person in Personalized 
Medicine, HEALTHAFFAIRS (May 2018), 
https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2018.0359 (claiming personalized 
medicine “is expected to shift patients’ involvement in their health care from passive to 
participatory. This high level of patient engagement is presumed to be a benefit of 
personalized medicine and has been touted as a way to empower patients to be more 
involved in their health.”). 
 7 Miliard, supra note 4; see also Annabel Action, What You Need to Know About the 
Future of Healthcare, FORBES (July 14, 2017, 10:11 AM), 
https://www.forbes.com/sites/annabelacton/2017/07/14/the-future-of-health-its-in-your-
hands/#5a18e01b2af2 (describing that individual consumers want to be in control and have 
options tailored specifically to them when it comes to healthcare). 
 8 Antonio Regalado, 2017 was the year consumer DNA testing blew up, MIT TECH. 
REV. (Feb. 12, 2018), https://www.technologyreview.com/s/610233/2017-was-the-year-
consumer-dna-testing-blew-up; Ancestry, Behind the Scenes: Courtney | Ancestry Stories | 
Ancestry, YOUTUBE (May 2, 2018), https://www.youtube.com/watch?time_continue= 
1&v=LWith5YzlXA (telling the story of an AncestryDNA user who went to Ghana to learn 
more about the ethnic group she discovered she was most likely related to). 
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for various conditions and diseases.9 This process can be done without having 
to leave the house.10 The means of obtaining this information is similar amongst 
a variety of different brands on the market: a person answers a few personal 
questions, orders the kit, collects a sample, registers the kit, sends it back and 
waits for the results.11 In order to collect a customer’s DNA, direct-to-consumer 
DNA companies (“Companies”) require either a swab of the cheek or a saliva 
sample. Generally, with a saliva sample, there is a fill line in the tube that is 
provided, that requires the consumer to produce enough saliva to reach that 
line.12 In an individual sample the Company will find “cells from the inner lining 
of your cheeks, plus white blood cells that are naturally present in saliva.”13 
Next, “the lab’s processing steps will break these cells open, [and] separate their 
DNA from everything else” in order to analyze the information and determine 
what an individual’s genetic makeup is.14 
 
Companies emphasize the importance of registering the kit before shipping it 
back.15 Failure to register the Testing Kit will prevent a person from accessing 
the results.16 23andMe, for example, provides “when you register your kit, you 
must use your real name. Once your kit has been registered, you may change 
your online profile name to any name you wish to use,” this is in included as an 
added layer of protection for an individual’s information.17 Companies use a 
barcode storing system to protect the individual’s privacy by linking the sample 
and company-stored reports to a unique barcode.18 Accordingly, the individual’s 
name does not appear on the kits themselves.19 
                                                          
 9 Lesley Fair, DNA test kits: Consider the privacy implications, FED. TRADE. COMM’N. 
(Dec. 12, 2017), https://www.consumer.ftc.gov/blog/2017/12/dna-test-kits-consider-
privacy-implications. 
 10 Top Five Questions About Ancestry DNA, ANCESTRYDNA, 
https://www.ancestry.com/dna/ (last visited Sept. 8, 2018) (AncestryDNA “predicts genetic 
ethnicity and helps find new family connections” by providing consumers with a saliva test 
that they can take at home and then mail in to a lab); Fair, supra note 9. 
 11 Molly K. McLaughlin, The Best DNA Testing Kits of 2018, PC MAG (Dec. 5, 2017, 
3:17 PM), https://www.pcmag.com/roundup/356975/the-best-dna-testing-kits; DNA Sample 
Collection Instructions, EASYDNA, https://www.easy-dna.com/resources/dna-testing-kit 
(last visited Nov. 12, 2018) (describing the five-step process for DNA collection: 1. Remove 
the oral swabs from DNA test kit; 2. Fill out basic information in envelope, including 
consent form; 3. Rub the swabs firmly for about one minute against the entire inner cheek 
surface; 4. Allow the swabs to dry for an hour; 5. Return envelope with swab). 
 12 See generally ANCESTRYDNA, https://support.ancestry.com/s/article/US-Taking-a-
DNA-Test (last visited Oct. 29, 2018) (providing information regarding the consumer saliva 
sample). 
 13 Beth Skwarecki, How Mail-In DNA Testing Services Work, VITALS (May 4, 2018, 
9:00 AM), https://vitals.lifehacker.com/how-dna-testing-services-work-182575929. 
 14 Id. 
 15 McLaughlin, supra note 11; Privacy Highlights, 23ANDME.COM, 
https://www.23andme.com/about/privacy (last visited Sept. 8, 2018). 
 16 McLaughlin, supra note 11. 
 17 Can I be Genotyped Anonymously?, 23ANDME, 
https://customercare.23andme.com/hc/en-us/articles/202907890-Can-I-be-genotyped-
anonymously-  (last visited Nov. 17, 2018). 
 18 McLaughlin, supra note 11. 
 19 Id.; AncestryDNA – Frequently Asked Questions, ANCESTRY, www.ancestry.com/dna 
(last visited Nov. 8, 2018) (follow the “FAQ” link at bottom of page to access “Frequently 
Asked Questions”). 
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While there are benefits to genetic Testing Kits, there are potential dangers in 
providing these Companies with an individual’s unique genetic code.20 An 
important concern is that when a person sends away their saliva sample, they 
also send their full genetic code.21 Peter Pitts of the Center for Medicine in the 
Public Interest stated that your full genetic code is “the most valuable thing you 
own.”22 The mutation pattern exclusive to your DNA is included in every cell in 
your body.23 While this does not reveal all of what makes an individual unique, 
your genes could disclose information relating to health, personality traits, 
family history, and information about relatives, and when this information is 
placed in the wrong hands, it bears the risk of abuse.24 Additionally, uneasy 
consumers worry about who actually gets this information when an individual 
submits to one of these types of genetic tests. Genetic testing companies promise 
not to sell or give this data away without consent.25 Usually these agreements 
come with a broad scope of consent as part of their initial contract, which allows 
the companies to use the DNA sample however it wants.26 
B.  Terms and Conditions of AncestryDNA and 23andMe 
When purchasing a genetic Testing Kit, the customers are presented with the 
company’s terms and conditions and informed consent documents.27 The terms 
                                                          
 20 Ruth Saunders, Legal Implications of Direct-to-Consumer Genetic Testing for 
Common Diseases, 1 QUEEN MARY L.J. 70, 70-71 (2010) (describing benefits of enabling “a 
person to get a better understanding of themselves for those who believe their genetic make-
up is a crucial component of their identity, or the psychosocial benefits of allowing an 
individual to make changes to their lifestyle or their surrounding environments by altering 
their diet or living conditions”); Gina Kolata, Poking Holes in Genetic Privacy, N.Y. TIMES 
(June 16, 2013),  https://www.nytimes.com/2013/06/18/science/poking-holes-in-the-
privacy-of-dna.html 
(advocating that consumers should acknowledge likely loss of privacy when providing 
genetic information). 
 21 Maggie Fox, What you’re giving away with those home DNA tests, NBC NEWS (Nov. 
30, 2017, 7:01 AM), https://www.nbcnews.com/health/health-news/what-you-re-giving-
away-those-home-dna-tests-n824776. 
 22 Id. 
 23 Id. 
 24 Kristen V. Brown, What DNA Testing Companies’ Terrifying Privacy Policies 
Actually Mean, GIZMODO (Oct. 18, 2017, 10:10 AM), https://gizmodo.com/what-dna-
testing-companies-terrifying-privacy-policies-1819158337; DNA kits raise privacy 
concerns, GAZETTE (Dec. 4, 2017), https://www.thegazette.com/subject/news/business/dna-
kits-raise-security-concerns-20171204. 
 25 Fox, supra note 21; see also How secure and private is AncestryDNA?, 
ANCESTRYDNA, https://www.ancestry.com/dna/ (last visited Nov. 18, 2018) (stating genetic 
data is not shared without consent or as legally required); 23ANDME.COM, supra note 15; 
Michael Kan, 23andMe, Ancestry: DNA is Safe with Us, PC MAG (Aug. 1, 2018, 8:02 PM), 
https://www.pcmag.com/news/362873/23andme-ancestry-and-others-address-genetic-data-
privacy?source=autosuggest 
(agreeing to guidelines requiring consent of DNA owner to transfer genetic information). 
 26 Brown, supra note 24. 
 27 What Happens to Your Genetic Data When you Take a Commercial DNA Ancestry 
Test?, CITIGEN (Dec. 7, 2017), http://www.citigen.org/2017/07/12/what-happens-to-your-
genetic-data-when-you-take-a-commercial-dna-ancestry-test/; Informed Consent Guidelines 
& Templates, U. MICH. RES. ETHICS & COMPLIANCE, https://research-
compliance.umich.edu/informed-consent-guidelines (last visited Oct. 17, 2018) (defining 
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and conditions are presented to customers at the time of purchase and include a 
privacy statement.28 Customers are required to consent to these general 
conditions in order to participate in the company’s services.29 The voluntary 
informed consent document relates to additional company-run research projects 
and is presented when individuals are registering their kit.30 
AncestryDNA is a DNA testing company that utilizes DNA science combined 
with the world’s largest online family history database resource to predict a 
person’s genetic ethnicity and assist individuals with finding new family 
connections.31 The results include information regarding the consumer’s genetic 
ethnicity estimates, which are estimates of the consumer’s historical origins of 
DNA, and identify potential DNA matches, linking an individual to others who 
have taken the AncestryDNA test.32 
Another popular genetic testing company is 23andMe.  23andMe is a genetic 
testing company that offers two personal genetic services, Health + Ancestry 
and Ancestry.33 Their Health + Ancestry service provides information on health 
risks, carrier status, traits, wellness, and ancestry, while their ancestry service 
provides information about where an individual’s DNA comes from and their 
family history.34 23andMe was authorized by the U.S. Food and Drug 
Administration to market the first direct-to-consumer genetic tests.35 23andMe 
and AncestryDNA are the two most popular companies among consumers 
seeking genetic testing.36 
AncestryDNA’s terms and conditions state “the purpose of the DNA Services 
is to provide genetic and genealogy results and related reports for your 
informational, recreational, educational, and research use.”37 Additionally, there 
is a clause that states: 
by submitting User Provided Content through any of the Services, you 
grant Ancestry a sublicensable, worldwide, royalty-free license to host, 
                                                          
informed consent documents as providing subjects with the information they need to make a 
decision to volunteer for a research study). 
 28 CITIGEN, supra note 27. 
 29 Id. 
 30 Id. (describing the Ancestry Human Diversity Project and 23andMe Research as 
being each company’s research projects). 
 31 ANCESTRY, supra note 19; see also Ken Chahine, DNA and the Masses: The Science 
and Technology Behind Discovering Who You Really Are, WIRED, 
https://www.wired.com/insights/2014/03/dna-masses-science-technology-behind-
discovering-really/ (last visited Nov. 9, 2018) (explaining how ancestry companies 
distinguish different ethnicities using DNA). 
 32 ANCESTRY, supra note 19. 
 33 What Services do you provide?, 23ANDME.COM, https://www.23andme.com (last 
visited Nov. 8, 2018); see FDA allows marketing of first direct-to-consumer tests that 
provide genetic risk information for certain conditions, U.S. FOOD & DRUG ADMIN. (Apr. 6, 
2017), https://www.fda.gov/newsevents/newsroom/Pressannouncements/ucm551185.htm 
(stating that the 23andMe GHR test was the first direct-to-consumer test approved by the 
FDA). 
 34 23ANDME.COM, supra note 33. 
 35 What is the history of the company?, 23ANDME.COM, https://www.23andme.com (last 
visited Nov. 10, 2018); see Molteni, supra note 1 (stating that the Food and Drug 
Administration regulated consumer DNA tests that relate to health). 
 36 Regalado, supra note 8. 
 37 Ancestry Terms and Conditions, ANCESTRY (June 5, 2018), 
http://www.ancestry.com/cs/legal/termsandconditions. 
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store, copy, publish, distribute, provide access to, create derivative 
works of, and otherwise use such User Provided Content to the extent 
and in the form or context we deem appropriate on or through any media 
or medium and with any technology or devices now known or hereafter 
developed or discovered.38 
This language may be of some concern for potential consumers since it is 
granting a broad licensing right in the user’s genetic results. 
23andMe has similar language in its terms and conditions stating, “unless you 
make a request for us to delete your account or delete certain Personal 
Information (i.e. User Content, etc.), we will store your Personal Information as 
long as your account is open.”39 It also states that some of your privacy rights 
“may be limited by local laws. Further, your right to access and deletion is not 
absolute and may not be available if . . . [it will] cause interference with 
execution and enforcement of the law and legal private rights.”40 Both 23andMe 
and AncestryDNA provide and emphasize that individuals who use their service 
continue to have ownership of their genetic information that was used to 
complete the tests.41 However, reading the other clauses in their respective 
privacy agreements together, suggests that an individual does not have complete 
control over their sensitive information. 
Nonetheless, these companies obtain consent from customers to share their 
identifiable data, but according to Peter Pitts “genetic testing firms sell the 
results of their tests to pharmacological companies and third-party 
laboratories.”42 Anonymizing DNA is a challenging task because it requires the 
data to be stripped of all identifying information, with no possibility that it can 
be reversed.43 Researchers have easily traced back an individual based on DNA 
that was posted anonymously on the Internet.44 Yaniv Erlich, of the Whitehead 
Institute for Biomedical Research, stated “we could actually identify all the other 
people in the family, basically by looking at public websites, public records of 
                                                          
 38 Id. 
 39 Consent to the use of Sensitive Information, 23ANDME (July 17, 2018), 
https://www.23andme.com/about/privacy. 
 40 Id. 
 41 ANCESTRY, supra note 37 (stating “AncestryDNA does not claim any ownership 
rights in the DNA that is submitted for testing. Any Genetic Information (your DNA and 
any information derived from it) belongs to the person who provided the DNA sample, 
subject only to the rights granted to AncestryDNA in this Agreement”); see also Terms of 
Service, 23ANDME, https://www.23andme.com/about/tos/ (last visited Nov. 10, 2018) 
(stating “[a]ny Genetic Information derived from your saliva remains your information, 
subject to rights we retain as set forth in these TOS”). 
 42 See Stephanie Pappas, Could Genetic Testing Companies Violate Your Privacy?, 
LIVESCIENCE (Dec. 1, 2017, 3:13 PM), https://www.livescience.com/61079-why-dna-
privacy-matters.html. 
 43 Id.; see also Anonymized verses Pseudonymized Data and Your Genetic Privacy, 
DNAEXPLAINED (May 31, 2018), https://dna-explained.com/2018/05/31/concepts-
anonymized-versus-pseudonymized-data-and-your-genetic-privacy/ (describing that 
“[a]nonymized data must be entirely stripped of any identifiable information, making it 
impossible to derive insights on a discreet individual, even by the person or entity who 
performed the anonymization.”). 
 44 Veronique Lacapra, Anonymity in Genetic Research Can Be Fleeting, NPR (Jan. 17, 
2013, 3:47 PM), https://www.npr.org/sections/health-
shots/2013/01/17/169609144/anonymity-in-genetic-research-can-be-fleeting. 
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these people, and Facebook and other websites.”45 This brings new concerns to 
people who submit to these genetic tests, because not only are they exposing 
themselves to the risk of their genetic information getting into the wrong hands, 
but are also exposing information about shared familial risk.46 Genetic 
discrimination is a serious concern for those considering genetic testing due to 
potential ways in which the findings could be used against consumers.47 
C.  Genetic Discrimination 
Genetic discrimination occurs when employers or insurance companies treat 
people differently “because they have a gene mutation that causes or increases 
the risk of an inherited disorder.”48 For example, a healthy 36-year-old woman’s 
application for life insurance was denied because her genetic testing came back 
as positive for the BRCA 1 gene, the gene that is associated with an increased 
risk of breast and ovarian cancer.49 However, many of these genetic tests do not 
reveal whether an individual will develop a disease or disorder, instead it will 
only tell an individual if they have a predisposition with an increased chance of 
developing a particular disease or disorder.50 Due to several other factors that go 
into the development of a condition, many individuals who test positive for 
genetic mutations never actually develop the condition.51 Testing positive alone 
is usually not enough to determine whether an individual will get the predisposed 
                                                          
 45 Id.; see also Ifeoma Ajunwa, There’s No Guarantee of Anonymity, N.Y. TIMES (Mar. 
4, 2015, 7:22 PM), https://www.nytimes.com/roomfordebate/2015/03/02/23andme-and-the-
promise-of-anonymous-genetic-testing-10/theres-no-guarantee-of-anonymity. 
 46 See Pappas, supra note 42 (explaining that disclosure of one person’s genetic 
information could potentially expose information about shared familial risks). 
 47 See Christina Farr, If You Want Life Insurance, Think Twice Before Getting A Genetic 
Test, FAST COMPANY (Feb. 17, 2016), https://www.fastcompany.com/3055710/if-you-want-
life-insurance-think-twice-before-getting-genetic-testing (describing an instance where a 
women was denied life insurance because her genetic test revealed that she had the BRCA 1 
gene and an increased risk of breast and ovarian cancer); see U.S. NAT’L LIBRARY OF MED., 
What is genetic discrimination?, GENETICS HOME REFERENCE (Aug. 21, 2018), 
https://ghr.nlm.nih.gov/primer/testing/discrimination (explaining that although regulations 
exist to stop genetic discrimination in the workplace and in providing health insurance, they 
do not protect against discrimination regarding life, disability, or long-term care insurance). 
 48 U.S. NAT’L LIBRARY OF MED., supra note 47; accord, Ifeoma Ajunwa, Genetic 
Testing Meets Big Data: Tort and Contract Law Issues, 75 OHIO STATE L. J. 1225, 1235 
(2014) (advocating that genetic discrimination is when an “individual is subjected to 
negative treatment, not as a result of the individual’s physical manifestation of disease or 
disability, but solely because of . . . genetic composition.”). 
 49 Farr, supra note 47. 
 50 Genetic Discrimination in the Workplace Factsheet, ACLU, 
https://www.aclu.org/other/genetic-discrimination-workplace-factsheet (last visited Aug. 17, 
2018) (referring to genetic testing for conditions such as breast cancer, a test which “cannot 
predict whether a person will actually develop the disease [or] . . .  if they have a genetic 
predisposition and a greater likelihood of developing cancer.”); e.g., Samantha Masunaga, 
What the new, FDA-approved 23andMe genetic health risk reports can, and can’t, tell you, 
L.A. TIMES (Apr. 14, 2017, 8:40 AM), http://www.latimes.com/business/la-fi-23andme-
reports-20170414-htmlstory.html (“the mere instance of a variant does not mean an 
individual has a disease or is certain to develop it. Likewise, the absence of a variant doesn’t 
guarantee that someone won’t ever get that disease . . . intended to provide genetic risk 
information to consumers”). 
 51 Genetic Discrimination in the Workplace Factsheet, supra note 50 (explaining that 
not all genetic tests can accurately determine if an individual will develop a certain disease). 
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condition.52 Nonetheless, employers and insurance companies may want to use 
this information against individuals in determining whether to offer them health 
insurance benefits, or when hiring or terminating employees.53 
D.  Health Insurance Portability and Accountability Act of 1996 (HIPAA) 
HIPAA is the most prominent American law regulating privacy and security 
of health information.54 HIPAA’s Privacy Rule governs the use and disclosure 
of protected health information (PHI) by covered entities and business 
associates.55 PHI is information that identifies or provides a reasonable basis to 
identify an individual.56 PHI can include demographic data relating to the 
individual’s “past, present or future physical or mental health condition . . . the 
provisions of health care to [the] individual . . . or [any] payment for the 
provision of health care” to the individual.”57 HIPAA regulates “covered 
entities”, which are health plans, health clearinghouse, and healthcare provider 
that transmits PHI electronically.58 Covered entities also include business 
associates, defined as a “person or organization, other than a member of a 
covered entity’s workforce, that performs certain functions or activities on 
behalf of, or provides certain services to, a covered entity that involve the use or 
disclosure of individually identifiable health information.”59 The privacy rule 
under HIPAA generally prohibits a covered entity from using or disclosing PHI 
unless approved by patients, except where this prohibition would result in an 
interference of treatment or efficient payment for health care services.60 
In 2013, the HIPAA Omnibus Rule amended HIPAA regulations to include 
genetic information in the definition of protected health information, thereby 
specifically applying HIPAA’s privacy protections to individuals’ genetic 
information.61 
                                                          
 52 Id. 
 53 See generally Farr, supra note 47 (describing a woman who was denied insurance 
coverage after testing positive for the BRCA gene, which is associated with an increased 
risk of breast and ovarian cancer). 
 54 Health Insurance Accountability and Portability Act of 1996, Pub. L. No. 104-191, 
110 Stat. 1936 (codified as amended in scattered sections of 42 U.S.C.); see Joanna Belbey, 
Privacy and Security: Learn From Best Practices for HIPAA Compliance, FORBES (Dec. 19, 
2015, 8:41 PM), https://www.forbes.com/sites/joannabelbey/2015/12/19/privacy-and-
security-learn-from-best-practices-for-hipaa-compliance/#3611367b71b4 (stating that 
HIPAA was one for the first Acts to regulate the privacy and security of client information). 
 55 45 C.F.R. § 160.103 (2014). 
 56 Id. 
 57 Id.; see also U.S. DEP’T OF HEALTH AND HUMAN SERVS., SUMMARY OF THE HIPAA 
PRIVACY RULE (July 26, 2013), https://www.hhs.gov/hipaa/for-professionals/privacy/laws-
regulations/index.html. 
 58 U.S. DEP’T OF HEALTH AND HUMAN SERVS., supra note 57. 
 59 Id. 
 60 45 C.F.R. § 164.506; see also U.S. DEP’T OF HEALTH AND HUMAN SERVS., USES AND 
DISCLOSURES FOR TREATMENT, PAYMENT, AND HEALTH CARE OPERATIONS (2013), 
https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/disclosures-treatment-
payment-health-care-operations/index.html (detailing circumstances under which private 
health information may or may not be disclosed). 
 61 See 45 C.F.R. §160.103 (defining protected health information); HIPAA: Impacts and 
Actions by States, NAT’L CONFERENCE OF STATE LEGISLATURES (May 2018) 
2018] Privacy of Information and DNA Testing Kits 169 
E.  The Genetic Information Nondiscrimination Act of 2008 (GINA) 
In the 13 year battle to pass GINA, the American population raised concerns 
that “they should not be penalized because they happened to be born at a higher 
risk for a given disease.”62 In 2008, Congress passed GINA “to prohibit 
discrimination on the basis of genetic information with respect to health 
insurance and employment.”63 GINA protects “genetic information”: an 
individual’s genetic tests, the genetic tests of a family member, or the 
manifestation of a disease or disorder in a family member.64 The manifestation 
of a disease or disorder in a family member can be used to predict an individual’s 
own genetic predisposition to certain diseases.65 This definition does not include 
the sex or age of an individual.66 The statute defines ‘genetic test’ as an “analysis 
of human DNA, RNA, chromosomes, proteins, or metabolites that detects 
genotypes, mutations, or chromosomal changes.”67 However, GINA excludes 
analysis of “proteins or metabolites that do not detect genotypes, mutations, or 
chromosomal changes” or inquiries that “are directly related to a manifested 
disease that could be reasonably detected by a health care professional.”68 
There are two parts to GINA: Title I of GINA applies to health insurance and 
Title II applies to employment-related matters. Title I prohibits group and 
individual health insurers from using a person’s genetic information to 
determine their eligibility and premiums.69 Additionally, Title I prevents 
insurers from requesting or requiring a person undergo a genetic test.70 Title II 
excludes employers from hiring, firing, or otherwise changing terms of an 
employee’s employment based on genetic information.71 Employers may not 
require, purchase or request from employees or their family members any 
genetic information.72 While GINA is a step forward in the protection of 
                                                          
http://www.ncsl.org/research/health/hipaa-a-state-related-overview.aspx. 
 62 Amy Harmon, Congress Passes Bill to Bar Bias Based on Genes, N.Y. TIMES (May 
2, 2008), https://www.nytimes.com/2008/05/02/health/policy/02gene.html. 
 63 Genetic Information Nondiscrimination Act of 2008, Pub. L. No. 110-233, 122 Stat. 
881, 881 (2008). 
 64 Id. at 906. 
 65 Perry W. Payne, Jr. et al., Heath Insurance and the Genetic Information 
Nondiscrimination Act of 2009: Implications for Public Health Policy and Practice, 124 
PUB. HEALTH REP. 328, 328 (2009); 42 U.S.C. § 2000ff(4). 
 66 42 U.S.C. § 2000ff(4)(C); U.S. DEP’T OF HEALTH AND HUMAN SERVS., “GINA” The 
Genetic Information Nondiscrimination Act of 2008: Information for Researchers and 
Health Care Providers, at 2 (Apr. 6, 2009), 
https://www.genome.gov/pages/policyethics/geneticdiscrimination/ginainfodoc.pdf. 
 67 42 U.S.C. § 2000ff(7)(A); Ortiz v. City of San Antonio Fire Dep’t, 806 F.3d 822, 826 
(5th Cir. 2015) (holding that “genetic tests” do not include other medical tests). 
 68 42 U.S.C. § 2000ff(7)(B). 
 69 Genetic Information Nondiscrimination Act of 2008, § 101(3)(a). 
 70 Id. at 888-89, 893-94; see also Kathy L. Hudson et al., Keeping Pace with the Times – 
The Genetic Information Nondiscrimination Act of 2008, 358 NEW ENG. J. MED. 2661, 2662 
(2008) (quoting Senator Edward Kennedy, who cosponsored the bill, stating 
“[d]iscrimination in health insurance and the fear of potential discrimination threaten both 
society’s ability to use new genetic technologies to improve human health and the ability to 
conduct the very research we need to understand, treat, and prevent genetic disease”). 
 71 Genetic Information Nondiscrimination Act of 2008, § 202(a); see also Hudson, 
supra note 70. 
 72 Genetic Information Nondiscrimination Act of 2008, § 202(b); see also Hudson, 
supra note 70. 
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individuals’ genetic information, there are significant pitfalls to its regulation, 
specifically in the lack of coverage in areas outside of the employment and health 
insurance context. 
F.  Relationship between HIPAA and GINA 
GINA and HIPAA each provide privacy protections for individuals, 
specifically relating to genetic information. Before GINA there was no federal 
regulation relating to genetic information.73 By early 2008, 32 states had enacted 
legislation providing varying levels of protection from genetic discrimination.74 
However, no minimum standard of protections existed besides the limited 
protections offered in HIPAA, which only applied to employer-based and 
commercially issued health insurance.75 Congress determined that HIPAA did 
not sufficiently protect individuals from potential genetic discrimination.76 For 
instance, an insurer was prohibited from “charging one individual in a group a 
higher premium than the rest of the group based on genetic information,” but the 
insurer could authorize “premiums for the entire group based on genetic 
information of one individual.”77 Congress also criticized HIPAA for limiting 
its application to only insurance companies writing group health policies, and 
exempting those writing policies only for individuals.78 
The enactment of GINA filled in some of the gaps in the HIPAA privacy rule. 
Prior to the enactment of GINA, HIPAA did not provide sufficient privacy 
protection to an individual’s genetic information. The enactment of GINA 
required HIPAA’s original privacy rule to be modified and expanded.79 For 
instance, prior to GINA there was no prohibition preventing health care plans 
from using or disclosing genetic information for underwriting purposes.80 While 
the HIPAA rules did not define what qualified as underwriting purposes, GINA 
defined the term with respect to health plans and the final rule adopted the GINA 
definition.81 Additionally, the final rule adopts GINA’s proposed rule adding 
                                                          
 73 See Legislative History of GINA, NAT’L HUM. GENOME RES. INST. (Apr. 17, 2017), 
https://www.genome.gov/27568535/legislative-history-of-gina (explaining that the first 
piece of legislation banning genetic discrimination was introduced thirteen years prior to 
GINA, but efforts to implement that law failed). 
 74 HIPAA: Impacts and Actions by States, supra note 61. 
 75 Alicia A. Parkman et al., Public Awareness of Genetic Nondiscrimination Laws in 
Four States and Perceived Importance of Life Insurance Protections, 24 J. OF GENETIC 
COUNSELING 512, 512-13 (2015). 
 76 See S. Rep. No. 110-48, at 10-15 (2007); Morse Hyun-Myung Tan, Advancing Civil 
Rights, the Next Generation: The Genetic Information Nondiscrimination Act of 2008 and 
Beyond, 19 HEALTH MATRIX: J. OF LAW- MED. 63, 96 (2009) (explaining “GINA 
compensates for HIPAA’s deficiencies.”). 
 77 S. REP. NO. 110-48, at 9-10. 
 78 S. REP. NO. 110-48, at 10 (noting that if a health insurance company does both group 
and individual policies then they would still be subject to HIPAA). 
 79 GEO. WASH. U. DEP’T OF HEALTH POL’Y, A SIDE-BY-SIDE TABLE COMPARING THE 
ADMINISTRATIVE SIMPLIFICATION REGULATIONS TO THE CHANGES IN THE PROPOSED INTERIM 
FINAL AND FINAL OMNIBUS RULES IMPLEMENTING HITECH, GINA, AND PSQIA, 
http://www.healthinfolaw.org/sites/default/files/article-files/HIPAA%20Side-by-
Side%20Table.pdf. 
 80 HIPAA: Impacts and Actions by States, supra note 61. 
 81 See GEORGE WASHINGTON UNIVERSITY DEPARTMENT OF HEALTH POLICY, supra note 
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reference to the underwriting prohibition such that “group health plans and 
issuers may not disclose genetic information that is protected health information 
for underwriting purposes” when disclosing summary health information to a 
plan sponsor.82 While the implementation of GINA improved the privacy 
protections of HIPAA, more needs to be done to further expand GINA. 
II. ANALYSIS 
A.  Employers Using Genetic Information to Discriminate 
Employers desire genetic information about current and prospective 
employees for various reasons, such as “to protect employee safety and health, 
to save money by avoiding high risk employees, and to protect themselves 
against future liability for the possible adverse health consequences that 
exposure to hazardous workplace chemicals might have on employees 
genetically predisposed for certain health conditions.”83 Additionally, employers 
may seek to ensure that employees can perform the necessary functions of a 
specified job.84 Accordingly, “[i]f a worker will become ill, and if the employer 
will be responsible for the medical costs as well as the output costs of the 
worker’s absence, then the predicted illness is nothing but a future dollar cost 
that the employer must consider and discount.”85 There are financial benefits in 
only hiring healthy workers.86 Hiring an unhealthy worker can add to potential 
                                                          
79, at 5 (proposing the GINA rule to define underwriting purposes with respect to health 
plan as: (i) rules governing benefit determinations/eligibility for benefits, or the 
determination of benefits/eligibility for benefits (including enrollment, continued eligibility, 
and changes in deductibles or other cost-sharing mechanisms in return for activities such as 
completing a health risk assessment or participating in a wellness program); (ii) premium or 
contribution calculations (including discounts, rebates, payments in kind, or other premium 
differential mechanisms in return for activities such as completing a health risk assessment 
or participating in wellness programs); (iii) the application of any preexisting condition 
exclusion; and (iv) other activities related to the creation, renewal, or replacement of a 
contract of health insurance or health benefits); Modifications to the HIPAA Privacy, 
Security, Enforcement, and Breach Notification Rules Under the Health Information 
Technology for Economic and Clinical Health Act and the Genetic Information 
Nondiscrimination Act; Other Modifications to the HIPAA Rules, 78 Fed. Reg. 5566, 5665 
(Jan. 25, 2013); 45 C.F.R. § 164.502(a)(5)(i) (2013). 
 82 GEORGE WASHINGTON UNIVERSITY DEPARTMENT OF HEALTH POLICY, supra note 79, 
at 7. 
 83 Abigail Lauren Perdue, Justifying GINA, 78 TENN. L. REV. 1051, 1100 (2011); see 
also Program Report, NAT’L HUM. GENOME RES. INST.: GENETIC INFO. AND THE WORKPLACE 
(Jan. 20, 1998) https://www.genome.gov/10001732/genetic-information-and-the-workplace-
report/ (explaining employers may “avoid hiring workers who they believe are likely to take 
sick leave, resign, or retire early for health reasons (creating extra costs in recruiting and 
training new staff), file for workers’ compensation, or use health care benefits excessively”). 
 84 See generally Paula Reece, The benefits of healthy employees, THE BUS. TIMES (Mar. 
30, 2012), http://thebusinesstimes.com/the-benefits-of-healthy-employees/. 
 85 Perdue, supra note 83, at 1101 (quoting Lance Liebman, Too Much Information: 
Predictions of Employee Disease and the Fringe Benefit System, 1988 U. CHI. LEGAL F. 57, 
82 (1988)). 
 86 Reece, supra note 84 (describing how fit employees are “less likely to get sick” and 
have “more energy”, as well as how health care expenditures are reduced); see Ben 
Greenfield, Unhealthy Employees Are Killing Your Bottom Line, HUFFPOST (May 3, 2013, 
4:12 PM), https://www.huffingtonpost.com/ben-greenfield/employee-
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expenses such as “decreased productivity, overtime payments to hire workers to 
cover absent employees’ shifts, higher job turnover, administrative costs 
inherent in hiring, recruiting, and training replacements, and higher workers’ 
compensation insurance premiums that result when an employee makes a claim 
for benefits.”87 
Consumer protection concerns arise if all employers could discriminate 
against those predisposed to incurring additional expenses on a company and 
require employees and prospective employees to disclose genetic testing.88 
Title II of GINA protects these consumers from these issues by “prohibiting 
most employers from using genetic information for hiring, firing, or promotion 
decisions, and for any decision regarding terms of employment.”89 This imposed 
additional deterrents on employers. GINA requires employers in “possess[ion] 
[of] genetic information about an employee or member” to “maintain[] [such 
information] on separate forms and in separate medical files and . . .  [treat] as a 
confidential medical record of the employee or member.”90 Unless the genetic 
information falls under an enumerated exception under GINA, an employer has 
a duty to refrain from disclosing such information.91 Accordingly, this requires 
employers to have additional safeguards to protect confidential employee 
medical information. The legislative comments accompanying GINA address 
this matter, stating, “[T]he covered entity must tell the health care professional 
not to collect genetic information as part of medical examinations intended to 
determine the ability to perform a job, and must take additional reasonable 
measures within its control if it learns that genetic information is being requested 
                                                          
wellness_b_3101223.html (describing how unhealthy employees who are “sick, overtired, 
or distracted by stress at home” causes an employer to lose “at least 115 productive hours 
each year due to chronic conditions like stress.”); Tatiana Spears, How Unhealthy 
Employees Are Killing Your Bottom Line, CAREATC (Sept. 8, 2017), 
https://www.careatc.com/ehs/unhealthy-employees-killing-your-bottom-line (stating how a 
University of Michigan study found that “the average health care cost for a healthy 
employee was roughly $3,000, and roughly $10,000 for an employee with at least one 
medical condition.”). 
 87 Perdue, supra note 83, at 1101; see Alicia Ciccone, Unhealthy Employees Cost 
Businesses $153 Billion in Lost Productivity, HUFFPOST (Oct. 18, 2011, 12:47 AM), 
https://www.huffingtonpost.com/2011/10/17/unhealthy-employees-cost-153-
billion_n_1016568.html (stating that a recent poll “estimates that unhealthy workers cost 
businesses $153 billion a year in lost productivity”). 
 88 See U.S. EQUAL EMP’T OPPORTUNITY COMM’N, GENETIC INFORMATION 
DISCRIMINATION (stating how “it is illegal to discriminate against employees or applicants 
because of genetic information” and that the Equal Employment Opportunity Commission 
under the Federal Trade Commission enforces such consumer protections). 
 89 DEP’T OF HEALTH & HUM. SERVS., “GINA”: THE GENETIC INFORMATION 
NONDISCRIMINATION ACT OF 2008 INFORMATION FOR RESEARCHERS AND HEALTH CARE 
PROFESSIONALS 2 (2009). 
 90 42 U.S.C. § 2000ff-5(a) (2008). 
 91 See 42 U.S.C. § 2000ff-5(b) (2008) (“An employer . . . shall not disclose genetic 
information concerning an employee . . . except - (1) to the employee . . . at the written 
request of the employee; (2) to a  . . .health researcher if the research is conducted in 
compliance with . . . Federal Regulations; (3) in response to an order of a court . . .; (4) to 
government officials investigating compliance with this chapter if the information is 
relevant to the investigation; (5) to the extent that such disclosure is made in connection 
with the employee’s compliance with . . . family and medical leave laws; or (6) to a Federal, 
State, or local public health agency . . . concerned with a contagious disease that presents an 
imminent hazard of death or life-threatening illness.”). 
2018] Privacy of Information and DNA Testing Kits 173 
or required.”92 These reasonable steps could include “no longer using the 
services of a health care professional who continues to request or require genetic 
information during medical examinations after being informed not to do so.”93 
Ultimately, employers must be proactive when it comes to preventing access to 
this protected information under GINA. 
Employee wellness programs give rise to new issues with employer 
implementation. While these programs are usually voluntary, many employees 
choose to participate. “Wellness programs” generally refer to “health promotion 
and disease prevention programs and activities offered to employees.”94 
Workplace wellness programs have two main goals: improving employee’s 
health and lowering their employer’s health care costs.95 Many of these 
programs require employees to answer questions on health risk assessment 
and/or undergo biometric screenings for risk factors.96 Some wellness programs 
“involve the exchange of health information between employees and their 
employers,” and are relevant to “the enforcement of GINA in cases where 
wellness programs request genetic information from employees.”97 
The Equal Employment Opportunity Commission (EEOC) has issued 
guidance regarding wellness programs and its relationship with GINA.98 The 
final rule issued by the EEOC states, “employers may provide limited financial 
or other inducements (also called incentives) in exchange for an employee’s 
spouse providing information about his or her current, or past health status as 
part of a wellness program, whether or not the program is part of the group health 
plan.”99 The final rule does not allow employers to induce children to participate 
in a wellness program if it would be “in exchange for information about their 
current health status or genetic information.”100 This decision was based in part 
on the concern that an employer, with access to employee’s children’s health 
information, including genetic information, may use it to discriminate against 
employees.101 This is compared to the disclosure of the health information of the 
employee’s spouse, where the final rule recognizes “there is minimal, if any, 
chance of determining information about an employee’s genetic make-up or 
predisposition to disease from health information about the employee’s 
                                                          
 92 Regulations Under the Genetic Nondiscrimination Act of 2008, 75 Fed. Reg. 68912, 
68926 (Nov. 9, 2010). 
 93 Id.; see also 29 C.F.R. § 1635.8 (mandating employers to tell healthcare providers 
they must not collect genetic information as part of an examination intended to evaluate if 
an employee can perform their job). 
 94 U.S. EQUAL EMP’T OPPORTUNITY COMM’N, EEOC’S FINAL RULE ON EMPLOYER 
WELLNESS PROGRAMS AND THE GENETIC INFORMATION NONDISCRIMINATION ACT 1 (May 17, 
2016). 
 95 Rebecca Greenfield, Workplace Wellness Programs Don’t Work, BLOOMBERG (Jan. 
26, 2018, 6:00 AM), https://www.bloomberg.com/news/articles/2018-01-26/workplace-
wellness-programs-really-don-t-work. 
 96 U.S. EQUAL EMP’T OPPORTUNITY COMM’N, supra note 94. 
 97 GINA and Employee Wellness Programs, NAT’L HUM. GENOME RES. INST. (Apr. 17, 
2017), https://www.genome.gov/27568501/gina-and-employee-wellness/. 
 98 Genetic Information Nondiscrimination Act, 81 Fed. Reg. 31143, 31143 (May 17, 
2016); see generally U.S. EQUAL EMP’T OPPORTUNITY COMM’N, supra note 94. 
 99 Id. 
 100 Id. 
 101 Id. 
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spouse.”102 This ruling changed the way wellness programs were treated under 
GINA, however, it does not change the fundamental prohibition of employment 
discrimination based upon genetic information.103 
This new rule was brought into question in AARP v. EEOC, where AARP 
filed a motion for a preliminary injunction to prevent these new regulations 
promulgated by the EEOC from becoming applicable on January 1, 2017.104 
Ultimately, the district court concluded the commission had failed to adequately 
justify its conclusion that incentives and penalties of up to 30 percent of the cost 
of an employee’s health insurance coverage does not render plan participation 
‘involuntary.’105 The court, however, is not concluding the EEOC has shown a 
substantial likelihood of success.106 This case raises important questions 
regarding the complex interaction of the ADA, GINA, the ACA, and HIPAA 
that implicate the public interest on all sides, and the court will have the 
opportunity to consider these questions carefully once the administrative record 
has been produced and further briefing ensues.107 The holding leaves the new 
rule in place and merely requires the EEOC to come up with justification for the 
specific shortcomings that the court found. Currently, the “EEOC wellness 
program regulations will remain effective through 2018, but will become null 
and void beginning on January 1, 2019.”108 The impending end of regulation 
creates uncertainty for employers regarding wellness program compliance under 
GINA beginning in 2019.109 
B.  Insurance Companies Using Genetic Information to Discriminate 
Title I of GINA prohibits health insurers from using genetic information to 
determine coverage, eligibility, or premiums; from requesting or requiring 
genetic tests for genetic information; and from obtaining genetic information for 
underwriting purposes.110 It also prohibits “individual insurers and issuers of 
                                                          
 102 Id.; Genetic Information Nondiscrimination Act, 81 Fed. Reg. 31143, 31147 (May 17, 
2016); see 29 CFR § 1635.8(b)(2)(A)(iii) (2018). 
 103 GINA and Employee Wellness Programs, NAT’L HUM. GENOME RES. INST. (Apr. 17, 
2017), https://www.genome.gov/27568501/gina-and-employee-wellness; see 29 CFR § 
1635.4; 42 U.S.C. § 2000ff-1(a). 
 104 A.A.R.P. v. United States Equal Emp’t Opportunity Comm’n, 226 F.Supp.3d 7, 10-
11 (D.D.C. 2016). 
 105 Id. 
 106 Id. 
 107 Id.; see Jonathan H. Adler, Federal court rejects EEOC wellness program rule, 
WASH. POST (Aug. 25, 2017), https://www.washingtonpost.com/news/volokh-
conspiracy/wp/2017/08/25/federal-court-rejects-eeoc-wellness-program-
rule/?noredirect=on&utm_term=.1b23688921c4 (highlighting the public interest in GINA 
from different lobbying groups). 
 108 Thomas Sullivan, AARP v. EEOC: Motion to Vacate Granted, POLICY MED. (May 4, 
2018), http://www.policymed.com/2018/01/aarp-v-eeoc-motion-to-vacate-granted.html. 
 109 Id.; John L. Barlament & Averi A. Niemuth, Employer-Sponsored Wellness 
Programs in Limbo After 2018, QUARLES & BRADY LLP (Jan. 18, 2018), 
https://www.quarles.com/publications/employer-sponsored-wellness-programs-in-limbo-
after-2018. 
 110 Jessica L. Roberts, Preempting Discrimination: Lessons from the Genetic Information 
Nondiscrimination Act, 63 VAND. L. REV. 439, 451 (2010); Genetic Information 
Nondiscrimination Act of 2008, Pub. L. No. 110-233, 122 Stat. 881 §§ 101-106 (2008). 
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supplemental Medicare coverage [from using] genetic information as a 
preexisting condition.”111 However, unless the health insurance companies do 
not receive this information on their own, the provision preventing insurance 
companies from acquiring this information is ineffective.112 For instance, even 
if a person does not directly reveal “information about their genetic tests or 
family history in an insurance application,” insurance companies can still have 
access if it is included in medical records requests, causing a loophole and 
eliminating the protection.113 This is known as an “incidental collection” 
provision and “notes that if a health insurance company inadvertently acquires 
genetic information while gathering other information about the individual, there 
will be no violation of GINA.”114 
The final rule addressed the reality of health insurance companies 
inadvertently receiving this information.115 It explains “if it is reasonable for an 
insurance company to expect that genetic information will be gathered as part of 
a request for medical records and information, the collection request must 
explicitly state that genetic information should not be provided.”116 If the 
healthcare professionals “do not comply with the notice and still include this 
information” it would “fall under the incidental collection provision, but the 
insurance companies still cannot use this information to discriminate against an 
individual.”117 Health insurance companies are not permitted to use this 
information for discrimination purposes and must do their due diligence to 
confirm that “medical underwriters are not taking any genetic information into 
account in any decision-making.”118 Insurance companies struggle with 
determining premiums and risk factors because they can no longer use genetic 
information in the underwriting process. 
C.  Areas Where GINA Falls Short 
1.  Long Term Care, Disability and Life Insurance 
GINA falls short in regulating long-term care, disability, and life insurance 
coverage. GINA applies only to employment and health insurance policies, thus 
leaving companies that sell long-term care, disability and life insurance in the 
clear when it comes to using individual’s genetics as a means of denying 
coverage.119 Robert Green, a researcher in the Genetics Department at Harvard 
                                                          
 111 Roberts, supra note 110, at 451; Genetic Information Nondiscrimination Act of 2008, 
122 Stat. 881 § 2753(c-d) (2008). 
 112 Anya Prince, Genetic Information and Medical Records – A Cautionary Tale for 
Patients, Healthcare Professionals, and Insurance Companies, 24 HEALTH L. 29, 29 (2012); 
Mark A. Rothstein & Laura Rothstein, The Use of Genetic Information in Real Property 
Transactions, 31 PROB. & PROP. MAG. 1, at 3 (2017). 
 113 Prince, supra note 112, at 29; Rothstein, supra note 112, at 2. 
 114 Prince, supra note 112, at 29; Rothstein, supra note 112, at 3; 42 U.S.C. § 300gg-
53(e)(3). 
 115 Prince, supra note 112, at 30. 
 116 Id. at 30. 
 117 Id. 
 118 Id. at 31. 
 119 Emily Holbrook, Life Insurance and the Genetic Information Nondiscrimination Act, 
GENETIC LITERACY PROJECT (Sept. 4, 2014), 
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Medical School, conducted a study examining how people react after they learn 
they have the gene associated with Alzheimer’s.120 The study revealed “people 
who discover they have the gene are five times more likely than the average 
person to go out and buy long term care insurance.”121 However, these 
individuals may be unable to acquire long-term insurance because “there’s 
nothing stopping the insurance companies from demanding to see the results of 
their genetic tests.”122 Moreover, “a long-term-care company could legally 
require someone to take a genetic test before selling [them] a policy.”123 This 
statement confuses many since these long term care policies cover the cost of 
nursing homes, assisted living facilities, home health aides and other things that 
people with these types of disease often need to use, but is not protected under 
GINA.124 
Many of the patients who seek long-term care insurance are troubled with the 
possibility that they may be denied insurance coverage, or risk paying higher 
premiums due to a pre-existing DNA mutation.125 Specifically, Northwestern 
Mutual Life Insurance Company asked potential Massachusetts customers about 
genetic testing, stipulating that refusal “to share results could lead to a declined 
application or an extra premium.”126 
Insurance companies are concerned that their business model would collapse 
if they are forced to accept higher-risk applicants.127 Life insurance companies 
use an underwriting process to assess an applicant’s risk.128 Based on the 
assigned risk class, an insurance company determines what premiums an 
individual will pay, or whether they will even grant coverage.129 Genetic 
information plays a significant role in the underwriting process of life insurance 
companies.130 Courts consider the life insurance underwriting process to be a 
method of “fair discrimination,” therefore excluding genetic information from 
                                                          
https://geneticliteracyproject.org/2013/09/04/the-tricky-landscape-between-life-insurers-
science-and-consumers. 
 120 David Schultz, It’s Legal For Some Insurers To Discriminate Based on Genes, NPR 
(Jan. 17, 2013, 6:04 PM), https://www.npr.org/sections/health-
shots/2013/01/17/169634045/some-types-of-insurance-can-discriminate-based-on-genes. 
 121 Id.; see Gina Kolata, New Gene Tests Pose a Threat to Insurers, N.Y. TIMES (May 13, 
2017), https://www.nytimes.com/2017/05/12/health/new-gene-tests-pose-a-threat-to-
insurers.html (describing a man who had the genetic mutation that increases the risk of 
developing Alzheimer’s disease who applied for long-term care insurance without telling 
the insurance company about the genetic test which revealed he had the gene). 
 122 Schultz, supra note 120. 
 123 Id. 
 124 See generally Education & Outreach, Understanding Long-Term Care Insurance, 
AARP (May 2016), https://www.aarp.org/health/health-insurance/info-06-
2012/understanding-long-term-care-insurance.html (summarizing the coverage of long-term 
care insurance coverage and exceptions). 
 125 Peikoff, supra note 4, at D1. 
 126 Id. 
 127 Farr, supra note 47. 
 128 KAROL K. SPARKS, INSURANCE ACTIVITIES OF BANKS § 16.02[A][3] (2nd ed. Supp. 
2018). 
 129 Id. 
 130 Brianna E. Kostecka, GINA Will Protect You, Just Not From Death: The Genetic 
Information Nondiscrimination Act and its Failure to Include Life Insurance within its 
Protections, 34 SETON HALL LEGIS. J. 93, 109 (2009). 
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this process might have a negative impact on life insurance companies.131 “Fair 
Discrimination” in the life insurance industry is not an issue “because the 
unequal treatment of people with unequal risks is a necessary and accepted 
characteristic of life insurance.”132 But, if these insurance companies no longer 
have access to genetic information in underwriting, adverse selection can 
occur.133 Adverse selection is the “process by which consumers make insurance 
decisions based on risk characteristics that are known to them but not revealed 
to the insurer.”134 This could enable “consumers to obtain insurance at cheaper 
rates than they would otherwise qualify for.”135 
Adverse selection raises concerns “of the possibility of industry  
dissolution . . . [causing p]rices for policies to drastically increase, leading to a 
decreased number of purchased policies and ‘potential insolvency for 
insurers.’”136 These competing concerns need to be addressed by lawmakers. 
Congress should prioritize individuals’ protection from discrimination in 
obtaining health and life insurance by expanding GINA. 
2.  Education 
GINA also falls short in the education arena. Since GINA only applies to 
employers and health insurance, it excludes the potential for genetic 
discrimination in the school setting. In Chadam v. Palo Alto Unified School 
District, the parents of a sixth grade boy allege that the parents of a sixth grade 
boy alleged that a school district violated his son’s rights by forcing him to 
transfer schools based off his genetic information.137 As soon as their son was 
born, he underwent emergency surgery to correct a health defect, and during this 
process his DNA was analyzed.138 The DNA test revealed the son had the genetic 
markers linked with cystic fibrosis, and he has been monitored ever since with 
no development of the condition.139 The school district learned of the boy’s 
                                                          
 131 Id. 
 132 Kostecka, supra note 130, at 109; but see Telles v. Comm’r of Ins., 574 N.E.2d 359, 
361-62 (Mass. 1991) (explaining that under Massachusetts law, “unfair discrimination” in 
life insurance occurs when individuals of the same class and equal expectation of life are 
treated differently). 
 133 Kostecka, supra note 130. 
 134 Knowledge@Wharton, Genetic Testing’s Uneasy Relationship with Life Insurance 
(Mar. 1, 2000), http://knowledge.wharton.upenn.edu/article/genetic-testings-uneasy-
relationship-with-life-insurance. 
 135 Id. 
 136 Kostecka, supra note 130, at 110. 
 137 Chadam v. Palo Alto Unified Sch. Dist., 666 F. App’x. 615, 616 (9th Cir. 2016). 
 138 Stephanie M. Lee, This Boy Was Thrown Out of School Because of His DNA, Parents 
Say, BUZZFEED NEWS (Feb. 5, 2016, 3:02 PM), 
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genetic information relating to cystic fibrosis after a teacher improperly 
disclosed that the boy had the disease to two other parents, whose children did 
have cystic fibrosis.140 After learning this, “the boy was regarded as disabled by 
the school district, and [] on the basis of the perceived disability, the school 
district decided to transfer the boy to another school to protect two other students 
at the school who have cystic fibrosis.”141 
Unfortunately, this case does not implicate GINA due to the lack of GINA 
protections in education context. The Chadam’s claimed that the school 
negligently violated Title II of the Americans with Disability Act of 1990 
(ADA), Section 504 of the Rehabilitation act of 1973, and the First Amendment 
by transferring their child to a different school.142 The case was dismissed by the 
district court but ultimately reversed in part by the Ninth Circuit with regards to 
the ADA and Section 504 claim.143 Both the ADA and Section 504 require 
public education and federally funded programs, respectively, to be free from 
discrimination.144 Both provisions mandate “individuals cannot be excluded 
from participating in or enjoying the benefits of education because of a 
disability.”145 They offer protections to individuals who fall in one of three 
classes: “[1] a person who has a physical or mental impairment that substantially 
limits one or more major life activities, [2] a person who has a history or record 
of such impairment, or [3] a person who is perceived by others as having such 
impairment.”146 The issue is whether genetic information can be classified as a 
“perceived disability” in order to offer individuals who are discriminated against 
based on their genetic information a cause of action. However, “most individuals 
with hereditary predispositions to [a disease] do not have disease effects which 
rise to the level of disability” and unless they are classified as disabled they 
cannot use the ADA as a means for relief.147 
This case could have been brought under California’s broader GINA statute, 
CalGINA, but, when asked, the attorney for the Chadams stated “[a] lawsuit 
under California law would, even if it would prevail, affect only California . . . 
This [federal suit] would affect other states, it would have a much broader 
application.”148 This illustrates the potential relief for similarly situated persons 
in contexts outside of employment and health insurance. Expanding GINA to 
include protections in education would address the issue of individuals who do 
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not rise to level of disability required by the ADA. 
3.  Real Property Transactions 
Real property may also pose a risk of genetic discrimination. Entities that have 
“an economic interest in the future health status of individuals may be tempted 
to use predictive genetic information to [determine] the health risk of individuals 
who are parties to real property transactions.”149 For example, “mortgage 
lenders, mortgage insurers, real estate sellers, senior living centers, retirement 
communities, and other entities involved in residential property might begin 
requiring genetic information as part of the application process.”150 Individuals 
with predispositions to certain health risks could expect their healthcare costs to 
increase if they do develop a disease or disorder which may ultimately affect 
their ability to pay a mortgage.151 For example, the “mortgage application of a 
women who has tested positive for the BRCA gene may be denied on the 
grounds of her predicted shortened life span and subsequent inability to pay the 
loan in full.”152 
Mortgage companies have an interest in knowing “that the borrower currently 
has and will continue to have the financial means to make payments” on their 
mortgage which typically require payments for 20 to 30 years.153 If an 
individual’s genetic test reveals that they are predisposed to certain high cost 
diseases which may develop within that 20 to 30 year repayment period, 
mortgage companies have an interest in knowing this information. 
The Equal Credit Opportunity Act prohibits credit discrimination on the basis 
of race, color, religion, national origin, sex, marital status, age, or because an 
individual receives public assistance.154 Genetic information is not included 
under the Act. Once an individual develops a disability they may be covered 
under the Fair Housing Act, but individuals who are predisposed to conditions 
that could lead to a disability are left without protections.155 In Texas 
Department of Housing & Community Affairs v. Inclusive Communities Project, 
Inc., a case involving the Texas Department of Housing and Community Affairs’ 
allocation of low income housing tax credits that was allegedly resulting in a 
disparate impact on African-American residents, the Supreme Court held that 
“disparate-impact claims are cognizable under the Fair Housing Act.”156 
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Disparate impact claims could be a form of redress for individuals who are 
subject to policies requiring mortgage applicants to submit genetic information. 
These policies “could be viewed as having a disparate impact on individuals 
with disabilities.”157 Alternatively, to prevent this type of discrimination, 
lawmakers should broaden GINA to include additional titles, and outline the 
prohibition of genetic information used for purposes of determining mortgages 
and other real property transactions. 
This same argument could be made in the case of private student loans. 
Currently, there are no reported cases of genetic information being used as a 
screening tool for the approval or denial of private student loans. However, in 
the future, it could be an issue as the price of higher education continues to 
increase.158 Lawmakers should be proactive and consider this type of 
discrimination in the reform of GINA. 
4.  Military, Federal Employees, and Indian Health Services 
GINA does not include specific protections for individuals who receive 
healthcare through the U.S. Military or Veteran’s Administration.159 The United 
States military currently uses and collects genetic information by requiring all 
service members to provide a “DNA sample to be used for the identification of 
remains.”160 The military may use this genetic information as a screening tool 
for potential members.161 This could be a benefit by helping “ensur[e] troop 
readiness, optimizing performance and in some cases reducing morbidity and 
mortality.”162 However, it would need to be weighed against the risk of 
“adversely impacting a [service] member’s career” by “identifying a deleterious 
genetic variant to reduce risk and enhance mission effectiveness.”163 
Although GINA does not cover military members, changes to military laws 
provide some protections. Since the passage of GINA, the military has 
incorporated “service members are entitled to compensation and benefits so long 
as there is no clear and unmistakable evidence that they had a hereditary or 
congenital disease at the time of enlistment, or if the disease was aggravated by 
their service.”164 It further states a “variant found in genetic testing cannot result 
in any action unless that individual suffers symptoms during their time of service 
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and those symptoms limit the member’s ability to carry out their duties.”165 The 
military is a special context in its “legitimate interest in obtaining information 
about [service member’s] physical and mental abilities[.]”166 Using genetic 
information in the military context should be weighed against the privacy risks 
to the individuals whose genetic information could be exploited. 
Native Americans who are covered under Indian Health Services are also not 
given GINA protections.167 This is because “Title I of GINA amends laws that 
do not have jurisdiction over these groups.”168 
Federal government employees are also not included in GINA’s protections. 
However, President Clinton signed Executive Order 13145 in February 2000 “to 
prohibit discrimination in federal employment based on genetic information.”169 
While Federal employees have been protected from genetic discrimination since 
early 2000, a uniform set of protections covering all of these groups would be 
beneficial in the reformation of GINA. 
D.  Obstacles with Bringing a Claim Under GINA 
Plaintiffs are faced with a substantial burden to file a claim under GINA. 
Congress borrowed heavily from other federal employment laws in writing the 
remedies and enforcement provisions in GINA.170 Similar to cases filed under 
Title VII and the ADA, plaintiffs wishing to bring a suit under GINA are first 
required to exhaust all administrative remedies.171 Plaintiffs who wish to bring 
their claim under Title I of GINA would first be “advised to go to [their] state 
health insurance commissioner for assistance . . . [and] HHS will enforce GINA 
protections when states fail to provide equally strong protections.”172 To bring a 
claim under Title II of GINA, plaintiffs must file a charge with the EEOC, who 
regulates this provision in the legislation.173 Plaintiffs “would need to obtain 
what is known as a ‘right to sue’ letter from the EEOC in order to move forward 
with a lawsuit against an employer.”174 They would need to obtain the letter 
“within 90 days of the alleged discriminatory employment action or they forfeit 
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their right to bring a claim.”175 Since many Title VII and ADA claims are 
dismissed based on the failure to exhaust administrative remedies, the same 
problem will likely arise with cases brought under GINA because plaintiffs are 
unfamiliar with the rigid deadlines involved.176 
GINA fails to contain a cause of action for disparate impact.177 As such, 
evidence of an employer’s actions resulting in a disparate impact on employees 
is insufficient to bring a cause of action under GINA.178 Thus, requiring 
plaintiffs to allege “specific instances where the employer intentionally 
discriminated against him or her on the basis of his or her genetic 
information.”179 As seen in other discrimination cases, it is famously difficult to 
prove intent to discriminate, hence creating an additional obstacle for plaintiffs 
to overcome when bringing a claim.180 
Despite the difficulties in bringing a GINA claim, some cases have succeeded 
under the law. The first GINA related case to be resolved in court was Lowe v. 
Atlas Logistics Group Retail Services.181 This case arose out of an incident when 
a grocery warehouse company discovered an employee had been “habitually 
defecating in one of its warehouses.”182 To resolve the mystery, “Atlas requested 
some of its employees, including Jack Lowe and Dennis Reynolds, to submit to 
a cheek swab.”183 The samples “were then sent to a lab where a technician 
compared the cheek cell DNA to DNA from the offending fecal matter.”184 The 
two suspected employees were not a match and ultimately filed suit under 
GINA.185 
The Court ruled in favor of Mr. Lowe and Mr. Reynolds, stating that “the 
plain language of the statute provides that employers may not ‘request . . . 
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genetic information with respect to an employee.’”186 Additionally the court held 
that GINA broadly defines the term ‘genetic information’ “to include 
information about an individual’s ‘genetic test,’ such as the [test] of Lowe’s and 
Reynold’s DNA here,” and ultimately concluded that this was a violation of 
GINA.187 This application was a broad interpretation of GINA and thus increases 
the scope of what the law covers.188 Jessica L. Roberts, director of the Health 
Law and Policy Institute at the University of Houston Law Center stated that 
“even if an employer, as in this case, did not seek an employee’s DNA to look 
for medical conditions, it was getting a trove a data that it arguably should not 
have.”189 Additionally, Ms. Roberts recognized that this raises the main concern 
for individuals that once an employer “gained access to [DNA], it could have 
theoretically tested for all kinds of other things, including issues relating to 
health, and used that information to discriminate.”190 
This case shows that there are successful outcomes for plaintiffs when it 
comes to the few areas that GINA is designed to protect and expanding GINA 
into other spheres should allow individuals with similar problems in areas 
outside of employment and health insurance context to be able to seek justice 
when their genetic information is improperly utilized. 
E.  Proposed Improvements to GINA 
When GINA was passed it was seen as “the first civil rights bill of the new 
century.”191 Unlike many before it, it was forward-looking by applying to a new 
form of discrimination that was not yet common. Expanding GINA would 
provide protections for individuals who are treated adversely because of their 
genetic information in a variety of settings.192 As genetic testing is becoming 
more frequent and available, especially in the direct-to-consumer testing market, 
problems arise for individuals outside of the employment and health insurance 
contexts. GINA needs to catch up with the technology to provide individuals 
with adequate protection of their genetic information. 
HIPAA and GINA only set a national floor for protections against genetic 
discrimination in employment and health insurance contexts and do not preempt 
more restrictive state laws.193 Accordingly, many states have created more 
stringent guidelines when it comes to protecting individual’s genetic information 
from being used as a means to discriminate.194 These more stringent state laws 
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that include a higher level of protection than offered in GINA are micro 
examples of what GINA could be if it was broadened. 
California is progressive when it comes to genetic discrimination, evidenced 
by its expansive anti-discrimination law, known as CalGINA.195 CalGINA 
expands GINA by including protection to additional areas including: “housing, 
provision of emergency services, education, mortgage lending and elections.”196 
Additionally, it extends the prohibition on genetic discrimination to employers, 
who have five or more employees. Whereas, GINA only applies to employers 
who employ fifteen or more people.197 
Connecticut law is broader than California’s law and applies “to employers 
with three or more employees.”198 A reform to GINA needs to allow coverage 
of entities that collect genetic information. Alternatively, a reform could “apply 
protections to the data itself, rather than making them dependent on who has the 
data.”199Additionally, Connecticut uses a broader definition of genetic 
information: “information about genes, gene products or inherited 
characteristics that may derive from an individual or family member.”200 In 
Burns v. Department of Public Safety, the court held that specific intent is not an 
element requisite to the Connecticut Fair Employment Practices Act prohibiting 
an employer from requesting or requiring genetic information from an 
employee.201 GINA should adopt this approach to overcome the burden of 
proving specific intent when bringing a claims. If GINA were amended to 
exempt the showing of specific intent for cases involving an employer or 
insurance company, more individuals would likely be successful in bringing 
claims regarding the protection of their genetic information. An amended GINA 
could dissuade employers and insurance companies from getting their hands on 
this information in the first place. 
Michigan requires “healthcare providers to obtain written informed consent 
from an individual prior to pre-symptomatic or predictive genetic testing” 
making it more expansive than GINA.202 Requiring the express written consent 
of the patient prior to genetic testing equips the individual with more knowledge 
about what they are doing, and what information they are potentially sharing. 
The Michigan Department of Health and Human Services satisfies the state’s 
written informed consent laws by providing sample booklets to individuals 
obtaining genetic testing.203 This booklet provides definitions for common 
                                                          
information in determining coverage for life insurance). 
 195 S.B. 559, 2011 Leg., Reg. Sess. (Cal. 2011). 
 196 ELECTRONIC FRONTIER FOUND., Genetic Information privacy, 
https://www.eff.org/issues/genetic-information-privacy (last visited Nov.18, 2018). 
 197 Hunton & Williams LLP, California Passes Law Prohibiting Discrimination Based 
on Genetic Information, HUNTON EMPLOY. & LAB. PERSPECTIVE (Oct. 21, 2011), 
https://www.huntonlaborblog.com/2011/10/articles/employee-privacy/california-passes-law-
prohibiting-discrimination-based-on-genetic-information. 
 198 Parkman, supra note 75, at 515. 
 199 ELECTRONIC FRONTIER FOUND., supra note 196. 
 200 Conn. Gen. Stat. § 46a-60(a)(11) (2017). 
 201 Burns v. Dep’t of Public Safety, 973 F.Supp.2d 141, 157-58 (D. Conn. 2013) 
(quoting Evening Sentinel v. Nat’l Org. for Women, 168 Conn. 26, 33 (1975)). 
 202 Parkman, supra note 75, at 514; MICH. COMP. LAWS § 333.17020(6) (2000). 
 203 MICH. DEPT. OF HEALTH & HUMAN SERVS., Informed Consent for Genetic Testing: 
2018] Privacy of Information and DNA Testing Kits 185 
genetic testing and other medical terms.204 Additionally, the booklet includes a 
frequently asked questions section, a discussion addressing the benefits and risks 
of genetic testing and includes a model form for physician use.205 On this form 
it explicitly states, “I have discussed the benefits and risks of this genetic test 
with my physician and . . . understand some genetic tests can involve possible 
medical, psychological or insurance issues for my family and me.”206  This type 
of comprehensive informational booklet and waiver is what should be required 
under GINA to provide individuals access to this information and to help them 
understand the benefits, and most importantly, the risks of submitting to genetic 
testing. 
Oregon also surpasses GINA by “requiring individual consent before a 
covered entity can obtain, retain, or disclose individually identifiable genetic 
information, and allowing an individual to inspect, request correction of, and 
obtain their genetic records.”207 It also requires “patient notification and the 
opportunity to opt-out of possible anonymous or coded use of genetic 
information by the covered entity or a third party.”208 Oregon gives “patients the 
right to refuse to have their information or biological samples used for research”, 
and can include a “blood sample, urine sample, or other materials collected from 
the body.”209 Therefore, health care providers in Oregon “must notify their 
patients that any specimens or health information collected will be available for 
. . . research unless the ‘patient opts’” out by completing a written form and 
submitting it to their health care providers.210 This severely limits the types of 
research that can be done without first obtaining a patients informed consent.211 
Knowledge is essential to reaching autonomy between the person receiving 
genetic testing and the company performing the tests. GINA would be more 
effective in protecting an individual’s genetic information if it were to include 
strict informed consent laws, similar to Oregon and Michigan. 
While it would be easier for Congress to leave it up to the states to provide 
for additional protections for genetic based discrimination, it raises additional 
issues, particularly regarding the inconsistencies in these laws from state to state. 
Some states protect individuals based on the type of policy they have, while 
other states do not offer protections beyond the minimum federal requirements. 
Additionally, “since hereditary [] predispositions are by nature a family affair – 
the [individual] initially seeking genetic testing could live in a state with strong 
legislative protections while their potentially at-risk relatives could reside in 
states with no protections.” GINA addressed this problem in a narrow context, 
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by creating a national floor of protections; however, a revamped GINA could 
provide additional protections to everyone in the United States and not rely on 
state legislatures to take actions on their own. 
III. CONCLUSION 
GINA was a major progressive measure for legislatures when it came to 
protecting genetic information. However, there are still certain subject areas that 
require further protection. GINA should be modified using states with stricter 
laws as guidelines for the appropriate use of genetic information, such as 
Oregon. The first step to more comprehensive protections of individual’s rights 
is increasing the knowledge and information that consumers receive before 
consenting to any genetic testing. This could be done by requiring DNA testing 
providers to provide potential consumers with information that illustrate the 
potential benefits and disadvantages of the testing. Another option would be to 
require individuals to take an online course explaining the benefits and 
disadvantages before they are permitted to participate in genetic testing. 
Secondly, as technology continues to develop and evolve over time, GINA needs 
to do the same and evolve its protections to apply anywhere discrimination may 
take place. 
 
